Value through Innovation27 July 2016

Clinical Study Results

  • PERSANTIN ® - Healthy
    Clinical Study Number 21.449
    Study Indication Healthy
    Product PERSANTIN ®
    Generic Name Dipyridamole
    Lab Code
    Clinical Phase I
    Study Title

    An open-labelled, randomised, 2-way crossover study to compare the pharmacokinetics of two different PERSANTIN® sugar coated tablets 75 mg p.o. (present and proposed formulation in France) q.i.d. for three days in healthy male volunteers

    Study Document Trial synopsis 21.449_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.